GCM
BSX icon

Gunpowder Capital Management’s Boston Scientific BSX Stock Holding History

Gunpowder Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.15K Hold
191
– – 0.01% 299
2026
Q1 		$12K Hold
191
– – 0.01% 270
2025
Q4 		$18.2K Buy
+191
New +$18.7K 0.01% 235

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Gunpowder Capital Management's BSX Position: Q2 2026 in Review

Gunpowder Capital Management held its Boston Scientific (BSX) position steady in Q2 2026 at 191 shares worth $8.15K. The position accounts for 0.01% of the portfolio, ranked #299.

Gunpowder Capital Management first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. The position peaked at $18.2K in Q4 2025. 1,465 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Gunpowder Capital Management held 191 shares of Boston Scientific worth $8.15K as of Q2 2026.
  • Gunpowder Capital Management left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up 0.01% of Gunpowder Capital Management's portfolio in Q2 2026, its #299 holding.
  • Gunpowder Capital Management first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • Gunpowder Capital Management's Boston Scientific position peaked at $18.2K in Q4 2025.
  • 1,465 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Gunpowder Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.